Showing results (121-130 of 224) with videos related to

Sort By:
Pageof 23
Investigational New Drugs|July 14, 2005
Human metabolism of [(14)C]indisulam following i.v. infusion in cancer patientsJan-Hendrik Beumer, Michel J X Hillebrand, Dick Pluim, et al.
Basic & Clinical Pharmacology & Toxicology|October 22, 2020
Toxicological analysis of azide and cyanide for azide intoxications using gas chromatographyMaaike A C Bruin, Douwe Dekker, Nikkie Venekamp, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 23, 2021
Development and validation of a combined liquid chromatography tandem-mass spectrometry assay for the quantification of aprepitant and dexamethasone in human plasma to support pharmacokinetic studies in pediatric patientsA Laura Nijstad, Matthijs M Tibben, Abadi Gebretensae, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 10, 2013
Quantitative determination of azacitidine triphosphate in peripheral blood mononuclear cells using liquid chromatography coupled with high-resolution mass spectrometryEllen J B Derissen, Michel J X Hillebrand, Hilde Rosing, et al.
Prostate Cancer and Prostatic Diseases|October 4, 2018
Impact of age on exposure to oral antiandrogen therapies in clinical practiceMarie-Rose B S Crombag, Merel van Nuland, Andries M Bergman, et al.
International Journal of Cancer|May 15, 2014
Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxelDilek Iusuf, Jeroen J M A Hendrikx, Anita van Esch, et al.
Journal of Analytical Toxicology|October 19, 2011
Determination of sunitinib and its active metabolite N-desethylsunitinib in sweat of a patientNienke A G Lankheet, Christian U Blank, Henk Mallo, et al.
Therapeutic Drug Monitoring|December 20, 2017
Fast and Straightforward Method for the Quantification of Pazopanib in Human Plasma Using LC-MS/MSRemy B Verheijen, Bas Thijssen, Hilde Rosing, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2009
ABCC2, ABCC3, and ABCB1, but not CYP3A, Protect against Trabectedin-Mediated HepatotoxicityRobert A B van Waterschoot, Rhandy M Eman, Els Wagenaar, et al.
Pageof 23